Profile: GSK's Arturo Gonzalez on ethics, corruption and window cleaning
This article was originally published in Scrip
Executive Summary
Arturo Gonzalez is head of regulatory affairs for GlaxoSmithKline Mexico. He began his career in consumer product development at Procter & Gamble before moving into regulatory affairs at the same company. He then started his own consultancy firm which was doing very nicely when GSK decided to snap him up.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.